Sage Journals: Discover world-class research

Abstract

There is mounting evidence to suggest that the epigenetic reprogramming capacity of the oocyte is superior to that of the current factor-based reprogramming approaches and that some factor-reprogrammed induced pluripotent stem cells (iPSCs) retain a degree of epigenetic memory that can influence differentiation capacity and may be linked to the observed expression of immunogenicity genes in iPSC derivatives. One hypothesis for this differential reprogramming capacity is the “chromatin loosening/enhanced reprogramming” concept, as previously described by John Gurdon and Ian Wilmut, as well as others, which postulates that the oocyte possesses factors that loosen the somatic cell chromatin structure, providing the epigenetic and transcriptional regulatory factors more ready access to repressed genes and thereby significantly increasing epigenetic reprogramming. However, to empirically test this hypothesis a list of candidate oocyte reprogramming factors (CORFs) must be ascertained that are significantly expressed in metaphase II oocytes. Previous studies have focused on intraspecies or cross-species transcriptional analysis of up to two different species of oocytes. In this study, we have identified eight CORFs (ARID2, ASF1A, ASF1B, DPPA3, ING3, MSL3, H1FOO, and KDM6B) based on unbiased global transcriptional analysis of oocytes from three different species (human, rhesus monkey, and mouse) that both demonstrate significant (p<0.05, FC>3) expression in oocytes of all three species and have well-established roles in loosening/opening up chromatin structure. We also identified an additional 15 CORFs that fit within our proposed “chromatin opening/fate transformative” (COFT) model. These CORFs may be able to augment Shinya Yamanaka's previously identified reprogramming factors (OCT4, SOX2, KLF4, and cMYC) and potentially facilitate the removal of epigenetic memory in iPSCs and/or reduce the expression of immunogenicity genes in iPSC derivatives, and may have applications in future personalized pluripotent stem cell based therapeutics.

Get full access to this article

View all access options for this article.

References

Aoto

, Saitoh

et al. 2008. Polycomb group protein-associated chromatin is reproduced in post-mitotic G1 phase and is required for S phase progression. J. Biol. Chem., 283:18905–18915.

Bar-Nur

, Russ

H.A.

et al. 2011. Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell, 9:17–23.

Becker

, Becker

et al. 2005. Differential in vivo binding dynamics of somatic and oocyte-specific linker histones in oocytes and during ES cell nuclear transfer. Mol. Biol. Cell, 16:3887–3895.

Byrne

2011. Global transcriptional analysis of oocyte-based and factor-based nuclear reprogramming in the nonhuman primate. Cell. Reprogram., 13:473–481.

Byrne

J.A.

, Nguyen

H.N.

et al. 2009. Enhanced generation of induced pluripotent stem cells from a subpopulation of human fibroblasts. PLoS One, 4:e7118.

Caetano

M.S.

, Vieira-de-Abreu

et al. 2002. NFATC2 transcription factor regulates cell cycle progression during lymphocyte activation: Evidence of its involvement in the control of cyclin gene expression. FASEB J., 16:1940–1942.

Crespo

A.V.

, Awe

J.P.

et al. 2012. Human skin cells that express stage-specific embryonic antigen 3 associate with dermal tissue regeneration. BioResearch Open Access, 1:25–33.

Dobson

A.T.

, Raja

et al. 2004. The unique transcriptome through day 3 of human preimplantation development. Hum. Mol. Genet., 13:1461–1470.

Fortier

J.M.

, Payton

J.E.

et al. 2010. POU4F1 is associated with t(8;21) acute myeloid leukemia and contributes directly to its unique transcriptional signature. Leukemia, 24:950–957.

10.

GeneCards.org 2012. “The GeneCards Human Gene Database.” www.genecards.org/

11.

Gurdon

J.B.

, Wilmut

2011. Nuclear transfer to eggs and oocytes. Cold Spring Harb Perspect Biol, 3. a002659, 10.1101/cshperspect.a002659.

12.

Heng

J.C.

, Feng

et al. 2010. The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells. Cell Stem Cell, 6:167–174.

13.

Houlard

, Berlivet

et al. 2006. CAF-1 is essential for heterochromatin organization in pluripotent embryonic cells. PLoS Genet., 2:e181.

14.

Irizarry

R.A.

, Ladd-Acosta

et al. 2008. Comprehensive high-throughput arrays for relative methylation (CHARM) Genome Res., 18:780–790.

15.

, Donaldson

I.J.

et al. 2012. The forkhead transcription factor FOXK2 promotes AP-1-mediated transcriptional regulation. Mol. Cell. Biol., 32:385–398.

16.

Jude

C.D.

, Climer

et al. 2007. Unique and independent roles for MLL in adult hematopoietic stem cells and progenitors. Cell Stem Cell, 1:324–337.

17.

Kim

, Doi

et al. 2010. Epigenetic memory in induced pluripotent stem cells. Nature, 467:285–290.

18.

Kim

, Zhao

et al. 2011. Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nat. Biotechnol., 29:1117–1119.

19.

Kim

S.K.

, Suh

M.R.

et al. 2005. Identification of developmental pluripotency associated 5 expression in human pluripotent stem cells. Stem Cells, 23:458–462.

20.

Kocabas

A.M.

, Crosby

et al. 2006. The transcriptome of human oocytes. Proc. Natl. Acad. Sci. USA, 103:14027–14032.

21.

Liu

Y.J.

, Nakamura

et al. 2012. Essential role of DPPA3 for chromatin condensation in mouse oocytogenesis. Biol. Reprod., 86:40.

22.

Lowry

W.E.

, Richter

et al. 2008. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl. Acad. Sci. USA, 105:2883–2888.

23.

Park

I.H.

, Zhao

et al. 2008. Reprogramming of human somatic cells to pluripotency with defined factors. Nature, 451:141–146.

24.

Pivot-Pajot

, Caron

et al. 2003. Acetylation-dependent chromatin reorganization by BRDT, a testis-specific bromodomain-containing protein. Mol. Cell. Biol., 23:5354–5365.

25.

Polo

J.M.

, Liu

et al. 2010. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat. Biotechnol., 28:848–855.

26.

Shogren-Knaak

, Ishii

et al. 2006. Histone H4-K16 acetylation controls chromatin structure and protein interactions. Science, 311:844–847.

27.

Takahashi

, Yamanaka

2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126:663–676.

28.

Takahashi

, Tanabe

et al. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131:861–872.

29.

Tsuzuki

, Taguchi

et al. 2011. Promotion and maintenance of leukemia by ERG. Blood, 117:3858–3868.

30.

Wakayama

, Jakt

M.L.

et al. 2006. Equivalency of nuclear transfer-derived embryonic stem cells to those derived from fertilized mouse blastocysts. Stem Cells, 24:2023–2033.

31.

Warren

, Manos

P.D.

et al. 2010. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell, 7:618–630.

32.

, Flowers

et al. 2012. Essential role of ARID2 protein-containing SWI/SNF complex in tissue-specific gene expression. J. Biol. Chem., 287:5033–5041.

33.

, Bai

X.H.

et al. 2007. XB130, a novel adaptor protein for signal transduction. J. Biol. Chem., 282:16401–16412.

34.

, Vodyanik

M.A.

et al. 2007. Induced pluripotent stem cell lines derived from human somatic cells. Science, 318:1917–1920.

35.

Zhao

, Zhang

Z.-N.

et al. 2011. Immunogenicity of induced pluripotent stem cells. Nature, 474:212–215.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.23 MB

Identifying Candidate Oocyte Reprogramming Factors Using Cross-Species Global Transcriptional Analysis

Abstract

Abstract

Get full access to this article

References

Supplementary Material